232 related articles for article (PubMed ID: 22091305)
41. Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome.
Mu L; Zhao Y; Lai Y; Li R; Qiao J
Clin Endocrinol (Oxf); 2018 Dec; 89(6):779-788. PubMed ID: 30106166
[TBL] [Abstract][Full Text] [Related]
42. Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS Classifications.
Si M; Xu W; Qi X; Jiang H; Zhao Y; Li R; Long X; Qiao J
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568475
[TBL] [Abstract][Full Text] [Related]
43. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I
Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
[TBL] [Abstract][Full Text] [Related]
46. Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome.
Sørensen AE; Udesen PB; Maciag G; Geiger J; Saliani N; Januszewski AS; Jiang G; Ma RC; Hardikar AA; Wissing MLM; Englund ALM; Dalgaard LT
Front Med (Lausanne); 2019; 6():242. PubMed ID: 31737638
[TBL] [Abstract][Full Text] [Related]
47. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
[TBL] [Abstract][Full Text] [Related]
48. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
Anaforoglu I; Algun E; Incecayir O; Ersoy K
Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
[TBL] [Abstract][Full Text] [Related]
49. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
50. Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.
Božić-Antić I; Ilić D; Bjekić-Macut J; Bogavac T; Vojnović-Milutinović D; Kastratovic-Kotlica B; Milić N; Stanojlović O; Andrić Z; Macut D
Eur J Endocrinol; 2016 Dec; 175(6):551-560. PubMed ID: 27634940
[TBL] [Abstract][Full Text] [Related]
51. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
52. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
53. Metabolic compromise in women with PCOS: earlier than expected.
Lana MP; Demayo S; Giannone L; Nolting M; D'isa E; Servetti V; Rolo G; Gutierrez G; Jarlip M
Rev Assoc Med Bras (1992); 2020 Sep; 66(9):1225-1228. PubMed ID: 33027449
[TBL] [Abstract][Full Text] [Related]
54. Metabolic syndrome in patients with the polycystic ovary syndrome.
Panidis D; Tziomalos K; Papadakis E
Expert Rev Endocrinol Metab; 2013 Nov; 8(6):559-568. PubMed ID: 30736140
[TBL] [Abstract][Full Text] [Related]
55. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
56. Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.
Tripathy P; Sahu A; Sahu M; Nagy A
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():60-65. PubMed ID: 29550643
[TBL] [Abstract][Full Text] [Related]
57. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
[TBL] [Abstract][Full Text] [Related]
58. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Harsha Varma S; Tirupati S; Pradeep TVS; Sarathi V; Kumar D
Diabetes Metab Syndr; 2019; 13(2):1065-1069. PubMed ID: 31336445
[TBL] [Abstract][Full Text] [Related]
59. Is ovarian volume a good predictor to determine metabolic syndrome development in polycystic ovary patients.
Sipahi M; Tokgöz VY; Keskin Ö; Atasever M; Menteşe A; Demir S
J Obstet Gynaecol; 2019 Apr; 39(3):372-376. PubMed ID: 30744441
[TBL] [Abstract][Full Text] [Related]
60. Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.
Çelik E; Türkçüoğlu I; Ata B; Karaer A; Kırıcı P; Eraslan S; Taşkapan Ç; Berker B
J Turk Ger Gynecol Assoc; 2016; 17(4):201-208. PubMed ID: 27990089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
